Invus Public Equities, L.P. Scholar Rock Holding Corp (SRRK) insider trading activity

Invus Public Equities, L.P. is of Scholar Rock Holding Corp. Currently has a direct ownership of 9.25 Million shares of SRRK, which is worth approximately $407 Million. The most recent transaction as insider was on Dec 10, 2024, when has been sold 1,600,000 shares (Common Stock) at a price of $41.65 per share, resulting in proceeds of $66,640,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.25M

17.85% 3M change

17.85% 12M change

Total Value Held $407 Million

Invus Public Equities, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	SELL Open market or private sale	$66,640,000 $41.65 p/Share	1,600,000 Reduced 14.75%	9,250,005 Common Stock
Nov 25 2024	SELL Open market or private sale	$16,107,094 $39.34 p/Share	409,433 Reduced 3.64%	10,850,005 Common Stock
Oct 12 2023	BUY Open market or private purchase	$16,939,468 $7.7 p/Share	2,199,931 Added 16.34%	11,259,438 Common Stock
Apr 28 2023	BUY Open market or private purchase	$202,911 $6.43 p/Share	31,557 Added 0.35%	9,059,507 Common Stock
Jan 09 2023	SELL Open market or private sale	$10,371 $9.48 p/Share	1,094 Reduced 0.01%	9,027,950 Common Stock
Jan 05 2023	BUY Open market or private purchase	$455,061 $9.33 p/Share	48,774 Added 0.54%	9,029,044 Common Stock
Oct 25 2022	BUY Open market or private purchase	$1,047,331 $8.04 p/Share	130,265 Added 1.43%	8,980,270 Common Stock
Oct 04 2022	BUY Open market or private purchase	$520,740 $7.89 p/Share	66,000 Added 0.74%	8,850,005 Common Stock
Oct 03 2022	BUY Open market or private purchase	$238,816 $7.03 p/Share	33,971 Added 0.39%	8,784,005 Common Stock

Also insider at

SEER

Seer, Inc. Healthcare

> 10% Shareholder

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

LXRX

LEXICON PHARMACEUTICALS, INC. Healthcare

Director

OMGA

Omega Therapeutics, Inc. Healthcare

> 10% Shareholder

SQZ

SQZ Biotechnologies Co Healthcare

> 10% Shareholder

GLYC

GLYCOMIMETICS INC Healthcare

IPE